RxDoctor Payments Data

Ruth Pinter

Family · North Hollywood, CANPI 1417116732

Payments from drug & device makers

$3,133in general payments, 2019–2025

Across 184 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Forte Bio-pharma LLC$1K
  • Collegium Pharmaceutical, Inc.$433
  • Novartis$410
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$308
  • Pfizer$113
  • Virtus Pharmaceuticals LLC$67
  • plus $455 from 15 others

What the payments were for

  • Food & beverage$3,121100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,133 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProlateOxycodone Hcl/Acetaminophen17$59,007
OxycontinOxycodone Hcl74$53,074
Xtampza ErOxycodone Myristate55$47,971
NucyntaTapentadol Hcl29$38,624
MovantikNaloxegol Oxalate55$23,375
Nurtec OdtRimegepant Sulfate13$22,412
LinzessLinaclotide29$20,463
Nucynta ErTapentadol Hcl13$20,042
Levorphanol Tartrate17$18,624
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen637$18,007
Aimovig AutoinjectorErenumab-Aooe12$14,588
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen317$14,071
BelbucaBuprenorphine Hcl16$11,399
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl64$7,495
Oxycodone Hcl298$6,941

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Nucynta Er, Belbuca$433$118,036113 claims
Forte Bio-pharma LLCProlate$1,346$59,00717 claims
PfizerNurtec Odt$113$22,41213 claims
AbbVieLinzess$54$20,46329 claims
Virtus Pharmaceuticals LLCLevorphanol Tartrate$67$18,62417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in North Hollywood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →